TNDM:NASDAQ
Tandem Diabetes Care Inc
16,50 USD
arrow_upward
+1,16%(+0,19) 1D
16,40 USD
arrow_downward
−0,61% (−0,10)bedtimeNakon radnog vremena
Zatvoreno: 1. lis, 16:00:01 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za TNDM...
Otvori
16,42 USD
Najviša
16,58 USD
Najniža
16,04 USD
Trž. kap.
1,15 mlr.
Prosj. kol.
1,89 mil.
Količina
2,40 mil.
52-tjed. najviša
29,65 USD
52-tjed. najniža
12,26 USD
EPS
−0,93 USD
Beta
1,55
Dionice u optjecaju
69,58 mil.
Broj djelatnika
2 tis.
Otvori
16,42 USD
Najviša
16,58 USD
Najniža
16,04 USD
Trž. kap.
1,15 mlr.
Prosj. kol.
1,89 mil.
Količina
2,40 mil.
52-tjed. najviša
29,65 USD
52-tjed. najniža
12,26 USD
EPS
−0,93 USD
Beta
1,55
Dionice u optjecaju
69,58 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Yahoo Finance
·
prije 1 sat
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
GuruFocus
·
prije 1 dan
TNDM Maintained by Citigroup -- Price Target Lowered to $20
Simply Wall Street
·
prije 2 dana
How International Pump Launch Has Changed Its Investment Story At Tandem Diabetes Care (TNDM)
Profil
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Tandem Diabetes Care Inc – informacije
Glavni izvršni direktorJohn Sheridan
Zaposlenici2,5 tis.
Osnovanosij 2006
Sjedište-
Sektor-
Web-lokacijatandemdiabetes.com